Christopher Borges

Christopher Borges currently serves as the Head of Non-Viral Gene Therapy and Genome Engineering at Sanofi, leading a multidisciplinary team within the Genomics Medicine Unit to advance projects across various therapeutic areas, including Oncology and Rare Diseases. Previously, Christopher held the position of Sr. Principal Scientist, focusing on genome engineering applications for rare genetic diseases and malignancies. Prior experience includes multiple roles at Editas Medicine in immunogenetics and foundational research at Massachusetts General Hospital leading to a Ph.D. in Immunology from Harvard University. Early career highlights include flow cytometry technical roles at both Columbia University Medical Center and Massachusetts General Hospital, where Christopher developed expertise in advanced analysis techniques. Academic qualifications include a Bachelor of Science in Biology from Emmanuel College, graduating summa cum laude.